Proposal Title: A phase 1, open-label, dose-escalation s

Project: Research project

Project Details

Description

Proposal Title: A phase 1, open-label, dose-escalation study to evaluate the safety and tolerability of SGN-LIV1A in patients with LIV-1-positive metastatic breast cancer
StatusActive
Effective start/end date2/1/1712/31/25

Funding

  • Seattle Genetics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.